In accordance with applicable privacy legislation, the company Kedrion S.p.a., controller of the data acquired via this website, hereby informs the user that said website does not use profiling cookies to send advertising messages tuned to preferences expressed when browsing the internet. This website installs third party cookies. Continuing to browse, including by scrolling down and clicking on website elements, equates to consent.
For more information, also as regards the technical cookies used by the website and to refuse consent to the installation of individual cookies, please refer to the complete cookies disclosure.
You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
-
CORPORATE - 20-07-2015
KEDPlasma welcomes donors to its new Augsburg collection center
Plasma collected in Germany is essential to Kedrion Biopharma’s plasma-derived therapies
read more -
CORPORATE - 29-06-2015
Humanitarian programme to reduce the gap in the access to clotting factors
Kedrion helps the WISH project come true: Italian CNS and the World Federation of Hemophilia sign agreement in London
read more -
CORPORATE - 30-04-2015
Kedrion SpA’s Shareholders approve 2014 financial statement
A 466 million euros’ turnover with a 9,8% rise on 2013
read more -
CORPORATE - 27-02-2015
Kedrion unveils its new manufacturing plant in Castelvecchio Pascoli
The company has invested over 67 million euros and is expected to create between 70 and 90 new jobs
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 